Display options
Cite
Propst A, Propst T, Dietze O, et al. Development of granulomatous hepatitis during treatment with interferon-alpha 2b. Dig Dis Sci. 1995;40(10):2117-8doi: 10.1007/BF02208993.
Propst, A., Propst, T., Dietze, O., Kathrein, H., Judmeier, G., & Vogel, W. (1995). Development of granulomatous hepatitis during treatment with interferon-alpha 2b. Digestive diseases and sciences, 40(10), 2117-8. https://doi.org/10.1007/BF02208993
Propst, A, et al. "Development of granulomatous hepatitis during treatment with interferon-alpha 2b." Digestive diseases and sciences vol. 40,10 (1995): 2117-8. doi: https://doi.org/10.1007/BF02208993
Propst A, Propst T, Dietze O, Kathrein H, Judmeier G, Vogel W. Development of granulomatous hepatitis during treatment with interferon-alpha 2b. Dig Dis Sci. 1995 Oct;40(10):2117-8. doi: 10.1007/BF02208993. PMID: 7587776.
Copy Download .nbib Format: NLM
Share it on

Dig Dis Sci. 1995 Oct;40(10):2117-8. doi: 10.1007/BF02208993.

Development of granulomatous hepatitis during treatment with interferon-alpha 2b.

Digestive diseases and sciences

A Propst, T Propst, O Dietze, H Kathrein, G Judmeier, W Vogel

PMID: 7587776 DOI: 10.1007/BF02208993

[No abstract available.]

References

  1. Lancet. 1992 Jan 11;339(8785):123-4 - PubMed
  2. Hepatology. 1986 May-Jun;6(3):349-53 - PubMed
  3. Gastroenterology. 1991 Sep;101(3):840-2 - PubMed
  4. Hepatology. 1988 May-Jun;8(3):712-7 - PubMed
  5. Hepatology. 1991 Dec;14(6):969-74 - PubMed

Substances

MeSH terms

Publication Types